RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
Walter and Eliza Hall Institute of Medical Research · Tel Aviv University · +5 more institutions
Abstract
RIPK3 and its substrate MLKL are essential for necroptosis, a lytic cell death proposed to cause inflammation via the release of intracellular molecules. Whether and how RIPK3 might drive inflammation in a manner independent of MLKL and cell lysis remains unclear. Here we show that following LPS treatment, or LPS-induced necroptosis, the TLR adaptor protein TRIF and inhibitor of apoptosis proteins (IAPs: X-linked IAP, cellular IAP1 and IAP2) regulate RIPK3 and MLKL ubiquitylation. Hence, when IAPs are absent, LPS triggers RIPK3 to activate caspase-8, promoting apoptosis and NLRP3-caspase-1 activation, independent of RIPK3 kinase activity and MLKL. In contrast, in the absence of both IAPs and caspase-8, RIPK3…
Citation impact
- FWCI
- 25.45
- Percentile
- 100%
- References
- 66
Authors
20- KEKate E. LawlorCorresponding
Walter and Eliza Hall Institute of Medical Research
- NKNufail Khan
Walter and Eliza Hall Institute of Medical Research
- AMAlison Mildenhall
Walter and Eliza Hall Institute of Medical Research
- MGMotti Gerlic
Tel Aviv University
- BABen A. Croker
Boston Children's Hospital, Harvard University
Topics & keywords
- Necroptosis
- Inflammasome
- Cell biology
- TRIF
- Programmed cell death
- Signal transducing adaptor protein
- Caspase
- RIPK1
- Good health and well-being